1. AB0024 Regulatory B Cell Functions Are Altered in Patients with Rheumatoid Arthritis and the Impairment of B Cell IL-10 Secretion is not Corrected by Efficient Therapies. (10th June 2014) Authors: Daien, C.I.; Audo, R.; Gailhac, S.; Mura, T.; Hahne, M.; Combe, B.; Morel, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0027 Phosphatidylserine Outer Layer Translocation is Implicated in IL-10 Secretion by B Cells in Healthy Controls and Rheumatoid Arthritis Patients. (9th June 2015) Authors: Hua, C.; Audo, R.; Hahne, M.; Combe, B.; Morel, J.; Daïen, C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 899 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0335 Are eular rheumatoid arthritis (RA) management recommendations applicable at the country level? similarities and differences with the recent french ra management recommendations. (12th June 2018) Authors: Hua, C.; Daien, C.; Gaujoux-Viala, C.; Cantagrel, A.; Dubremetz, M.; Dougados, M.; Fautrel, B.; Mariette, X.; Nayral, N.; Richez, C.; Saraux, A.; Thibaud, G.; Wendling, D.; Gossec, L.; Combe, B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0373 Integrating Treatment Goals of Physicians, Patients, and Payers during Treatment with Golimumab in Patients with Rheumatoid Arthritis. (10th June 2014) Authors: Combe, B.; Veale, D.; Burgos-Vargas, R.; Szűcs, G.; Leirisalo-Repo, M.; Yao, R.; Huyck, S.; Lyu, R.; Govoni, M.; Vastesaeger, N.; Weng, H.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0438 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis WHO HAD an Inadequate Response to Tnf-Alpha Inhibitors: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study. (10th June 2014) Authors: Schiff, M.; Combe, B.; Dörner, T.; Kremer, J.M.; Huizinga, T.W.; Veenhuizen, M.; Gill, A.; Zou, H.; Komocsar, W.; Berclaz, P.-Y.; Ortmann, R.; Lee, C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0444 Impact of Gender on the Response and the Tolerance to Treatment with Abatacept in RA Patients: Results from the "Orencia and Rheumatoid Arthritis" Registry. (9th June 2015) Authors: Nourisson, C.; Gottenberg, J.-E.; Mariette, X.; Mulliez, A.; Bardin, T.; Cantagrel, A.; Combe, B.; Dougados, M.; Flipo, R.-M.; Gaudin, P.; Vittecoq, O.; Schaeverbeke, T.; Sibilia, J.; Soubrier, M.; Ravaud, P.; Tournadre, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0516 An open-label randomized controlled study to evaluate the efficacy of etanercept (ETN) versus rituximab (RTX), in patients with active rheumatoid arthritis previously treated with RTX and TNF blockers. (23rd January 2014) Authors: Combe, B.; Dougados, M.; Logeart, I.; Lukas, C.; Mariette, X.; Puechal, X.; Saraux, A.; Schaeverbeke, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0814 SUSTAINED IMPROVEMENTS IN PHYSICAL FUNCTION, QUALITY OF LIFE, AND WORK PRODUCTIVITY WITH IXEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PREVIOUS INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR-INHIBITORS: 3-YEAR RESULTS FROM SPIRIT-P2 TRIAL. (2nd June 2020) Authors: Orbai, A. M.; Gratacos-Masmitja, J.; Dokoupilova, E.; Combe, B.; Constantin, A.; Gellett, A. M.; Sprabery, A. T.; Birt, J.; Geneus, V.; Nash, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0841 TARGET OUTCOMES IN PsA: SIMULTANEOUS ACHIEVEMENT of ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24. (13th June 2020) Authors: Smolen, J. S.; Behrens, F.; Liu Leage, S.; Sapin, C.; De La Torre, I.; Meszaros, G.; Schett, G.; Gossec, L.; Ostor, A.; Combe, B.; Van den Bosch, F. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0848 Rituximab treatment for spondyloarthritis. A nationwide series: Data from the air registry. (23rd January 2014) Authors: Wendling, D.; Dougados, M.; Berenbaum, F.; Brocq, O.; Schaeverbeke, T.; Mazieres, B.; Marcelli, C.; Le Parc, J.-M.; Bertin, P.; Robin, M.; Sibilia, J.; Lafforgue, P.; Prati, C.; Combe, B.; Gottenberg, J.-E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗